MDMA (exctasy) toxicity - NYSORA

Explore NYSORA knowledge base for free:

MDMA (exctasy) toxicity

Learning objectives

  • Diagnose and treat MDMA toxicity

Definitions and mechanisms

  • MDMA (3,4-methylenedioxymethamphetamine) ecstasy is a synthetic compound with structural and pharmacologic similarities to both amphetamines and mescaline
  • Typical effects include feelings of euphoria, wakefulness, intimacy, excitement, and a loss of inhibitions
  • It is mistakenly believed that it is a safe drug with little toxicity and a long duration of action
  • The effects of MDMA typically last anywhere from 3 to 6 hours
  • Effects are thought to result from alterations in serotonin, dopamine, and norepinephrine
  • The drug is commonly ingested orally in tablet form, however, the powder itself can be snorted
  • Absorbed via the GI tract with an onset of effect between 20 minutes and 1 hour after consumption
  • MDMA is profoundly serotonergic and can precipitate serotonin syndrome

Side effects associated with MDMA

Minor side effectsLife-threatening side effects
TrismusHyperpyrexia > 41.5°C
TachycardiaRhabdomyolysis
BruxismSerotonin syndrome
AnxietyAcute liver failure
Prolonged hangover Hyponatremia and cerebral edema

Signs and symptoms

System

Minor or moderate overdoseSevere overdose
CardiovascularDisseminated Intravascular Coagulation (DIC)
Intracranial hemorrhage
Severe Hypotension or Hypertension
Hypotensive bleeding
Central nervous
system
Hyperreflexia
Agitation
Mental confusion
Paranoia
Stimulant psychosis
Cognitive and memory impairment potentially to the point of retrograde or anterograde amnesia
Coma
Convulsions
Hallucinations
Loss of consciousness
Serotonin syndrome
MusculoskeletalMuscle rigidity
Rhabdomyolysis
RespiratoryAcute Respiratory Distress Syndrome
UrinaryAcute kidney injury (AKI)
OtherCerebral edema
Hepatitis
Hyperpyrexia
Hyponatremia

Complications

Risk factors

  • Ingestion of several doses at once or in a short period
  • Mixing MDMA with alcohol or other drugs
  • Vigorous physical activity
  • Use of MDMA in a hot environment

Diagnosis

  • Blood glucose levels
  • Electrolyte abnormalities
  • Urine, potassium, BUN, creatinine, creatine phosphokinase levels, and myoglobin levels for the evaluation of rhabdomyolysis and renal injury
  • LFTs for hepatotoxicity
  • Aspirin, alcohol, acetaminophen levels, and urine drug screening
  • ECG
  • Head CT, lumbar punction

Management

MDMA toxicity, exctasy, RSI, ketamine, rhabdomyolysis, hyperkalemia, succinylcholine, activated charcoal, evaporative cooling, ice packs, benzodiazepines, dantrolene, labetalol, cyproheptadine

Suggested reading

  • Davies N, English W, Grundlingh J. MDMA toxicity: management of acute and life-threatening presentations. Br J Nurs. 2018;27(11):616-622.
  • Nicholson Roberts, T., Thompson, J.P., 2013. Illegal substances in anaesthetic and intensive care practices. Continuing Education in Anaesthesia Critical Care & Pain 13, 42–46.
  • Hall, A.P., Henry, J.A., 2006. Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management. British Journal of Anaesthesia 96, 678–685.

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com